In “Myths of National Consolidation, the Holodomor, and the Holocaust: A Response to Roman Serbyn,” (http://ukraineanalysis.wordpress.com/2011/09/) John-Paul Himka counters my critique (<http://ukraineanalysis.wordpress.com/2011/08/) of the paper he delivered at the University of Alberta on 28 March 2011 (http://ukraineanalysis.wordpress.com/2011/08/). In his rejoinder, Himka touches on national myths, the place of Holocaust and Holodomor in Ukrainian history, the notion of genocide, and other related issues. All these questions beg further discussion, but to do them justice it would require a longer exposition than this article allows. I shall concentrate my attention on the Ukrainian genocide and comment on Himka’s evasive methodology in debating that subject
Himka and Snyder
An initial difficulty in discussing the Ukrainian genocide with Himka is his unwillingness to adopt a clear and firm position on the concept of genocide. He states that he is reluctant to use the term…
The second of three readings of Bill C-45 – “An Act respecting the legal access to cannabis and the control of its production, distribution and sale”, was still being debated in parliament, before the summer break.
The latest publication of the Cannabis Act is from the first reading and the stated objectives are “to prevent young persons from accessing cannabis, to protect public health and public safety by establishing strict product safety and product quality requirements …”
The debate in the second reading stems around the Canadian Medical Association (CMA)’s outburst that “legalizing weed will harm youth”. In addition, other Big Pharma supporters, such as the editor in chief of the Canadian Medical Association Journal stating that the new legislation is not protecting Canada’s youth.
Other Big Pharma supporters, such as Health Canada, claim that not enough research and scientific evidence exists on the safety of cannabis.
A study by the institute for Clinical Evaluative Sciences found that an alarming number of school age youth have been diagnosed with ADHD and prescribed harmful antipsychotic drugs.
The Diagnostic & Statistical Manual (DSM 5) is the basis for the listing of mental disorders in the International Classification of Diseases and is used throughout the world. Most of the disorders contained in this manual are said to be caused by a chemical imbalance in the brain.
According to the Citizens Commission on Human Rights (CCHR), the theory that mental disorders are caused by a chemical imbalance in the brain is just an unproven opinion, not fact, since mental disorders are determined by votes, not science. Furthermore, “Governments, insurance companies and private individuals pay billions of dollars each year to psychiatrists in pursuit of cures that psyhiatrists admit do not exist”.
Numerous strains of cannabis have the medicinal health benefits of relieving anxiety, stress, depression and insomnia without any harmful side effects. In fact, GW Pharma has filed numerous patents on the medicinal benefits of cannabinoids for mental health disorders and a number of diseases, including cancer.
Although prescription bensodiazepines (diazepam, doral, xanax, valium, ativan, etc), used to treat a number of mental disorders, are a leading cause of death in Canada, cannabis has the ability to replace a number of these prescription pills – without harmful side effects.
When doing your own research on the medicinal benefits of cannabis, there is the Big Pharma side vs. Mother Nature. You decide.
With the adoption of the United Nation’s Single Convention on Drug Control in 1971, it became necessary for the international forensic community to be able to differentiate “drug-type” cannabis from “fiber-type”.
Due to the restricted research and limited knowledge of cannabis at the time, the United Nations adopted and recommended the ratio of the two main constituents of cannabis -THC and CBD . In other words, if the ratio of THC:CBD was greater than 1 – it was deemed a drug; if the ratio was less than one, the plant was deemed to be hemp.
Cannabis is finally being accepted as the medicinal plant it is and as countries move towards accepting recreational cannabis, why is the industry still only focused on the ratio of THC to CBD????
To emphasize the meaningless of the THC to CBD ratio, the following strain fingerprints are for your perusal:
With the exception of the ACDC strain above, the cannabinoid – CBD (cannabidiol) is only present in trace amounts in the above strain fingerprints, relative to CBG, CBC and or THCV.
The above strain fingerprints not only disclose the major cannabinoids present in a given strain, it also discloses the terpenes that are present. Terpenes and cannabinoids are produced in the heads of the glandular trichomes, produced during the flowering stage of unfertilized female plants.
For indepth research on cannabinoids and terpenes, the following e-book is available at Amazon and provides indepth information on cannabinoids, terpenes, strain fingerprints, plus so much more.
The synergistic benefits of the plant’s naturally produced cannabinoids and terpenes provide a great deal of additional benefits relative to just THC or CBD. As consumers and patients of cannabis become more educated on the full potential of this plant, it is important to insist on reviewing the full strain footprint from licensed vendors. In this way, the quality of product should increase, along with indepth research on the medicinal qualities of this plant.
Big Pharma Interrupted – their profits are threatened by whole plant based cannabis medicine. The pharmaceutical industry is against legalizing the plant on the basis that it fails to protect the safety of children. If that concern had a miniscule of truth to it, the industry would NOT prescribe their harmful psychotropic drugs to children.
The largest pharmaceutical market in the world is the U.S. – representing 35% of the global market. Those states that have adopted a medical cannabis policy are witnessing a significant drop in prescription drugs including those for pain and for symptoms associated with chemotherapy – two very lucrative money making conditions for Big Pharma).
The pharmaceutical industry is the largest industry raking in massive amounts in revenues at the expense of people suffering from acute health challenges to life threatening diseases. In fact, the Washington Post published specific results for reduced prescriptions including painkillers, anxiety, nausea, psychosis, sleep disorders and depression in those states with a medical marijuana law.
What is the pharmaceutical industry doing about a plant that can reduce their revenues by at least $4 billion annually? This industry is spending an obscene amount of money to discredit this plant as harmful, untested, dangerous and of no use, unless it is of pharmaceutical grade.
When you want to know something about the emerging medical and recreational cannabis industry, where do you turn to for unbiased, current and up to date correct information?
Who owns the online Cannabis News?
Leaf Science has been bought out by ‘a group or web of companies with questionable ethics’ and Leafly was bought out by Privateer Holdings a closely connected corporation to Tilray, one of Canada’s Licensed Producers (LP). Who is Lift.co associated with? My guess is the Tweed – Bedrocan conglomerate.
Why should this matter?
This matters because the information espoused by these so called “newsgroups” are subjectively tainted!
This author has asked each of Canada’s Licensed Producers (LP’s) “Can you supply a full fingerprint of each strain you are selling because the regulated percentage of just THC and CBD is useless …?” To date, NO response has been received by any of the LP’s contacted.
Also, the LP’s in Canada have been stockpiling their inventory (evidence is through Health Canada’s website) which is further evidence that the THC reported in their strains are no longer accurate since THC degrades to CBN within six months.
Cannabis research at the Division of Narcotic Drugs, United Nations, Geneva is mandated with the primary function of internationally coordinating cannabis research in order to avoid unnecessary duplication of effort.
The emphasis of this international research was “to elucidate the effects of the compounds responsible for the psychoactive effects of cannabis in man, to quantify the constituents or their metabolites in biological fluids, to determine their toxicity and side effects and to correlate these data with the social effects of the drug.”
At the large number of new and unpublished cannabis research:
The Symposium revealed that a large amount of knowledge had been accumulated on the chemistry of cannabis and the synthesis of the cannabinoids and their metabolites. The report stated that there still remains some uncertainty as to how much THC is absorbed by smoking, to give the biological high. It concluded that THC and cannabis of known potency can be used with confidence in large scale clinical trials. It was determined that within the next few years (by 1975 ?), the clinical data will shed new light on the two basic questions of the UN “How dangerous is cannabis?” and “What should we do about it?”
In other words, the United Nations 1961 Single Convention on Drug Control, vilified this plant without corroborating evidence that supported its placement as a dangerous drug.
The first research published about the cannabinoids in ‘Indian Hemp” was in 1843 by Dr. W.B. O’Shaughnessy. The CBN cannabinoid, cannabinol, was first identified in 1899 and it wasn’t until the 1940’s when researchers were able to identify other cannabinoids including: THC, CBD and CBN.
Between 1940 and the implementation of the Single Convention on Drug Control in 1961, extensive research uncovered medicinal properties associated with these preliminary cannabinoids. The first patent filed regarding a compound of cannabis was in 1942 when cannabidiol (CBD) was isolated.
After the 1961 Convention was concluded, Raphael Mechoulam and his research partners at the Hebrew University of Jerusalem isolated and established the structure of THC and synthesized it in 1971. This discovery lead to further research and identification of a number of other cannabinoids that possessed fascinating medicinal properties.
Despite the fact that cannabis oil was included as medicine in the British and US Pharmacopoeia and used since the beginning of time as medicine in the east, it posed a threat to the pharmaceutical industry’s plan of taking over medicine. As a result, it became subject to criminal controls following the adoption of the Single Convention on Drug Control, and was then deemed a dangerous Schedule I drug – with a high potential for abuse; no accepted medical use and no known safety standard for its use. Despite these outlandish claims, the government continued to file patent applications on their research, without any competition.
The UN established itself as the international competent organization to handle the control of narcotic drugs through its numerous agencies, committees, commissions, and treaty resolutions it set up.
The UNITED NATION – is NOT in a position to dictate on Cannabis
Hemp is grown for its seeds or stalk, NOT for female unfertilized flowers. In other words, there is very little medicinal cannabinoids found in industrial hemp and using ration of THC to CBD will be a false positive fibre type if the ratio is < 1.
Although the hemp plant does not produce a significant quantity of medicinal cannabinoids, industrial hemp seeds do contain a plethora of health benefits and has its own unique medicinal properties, such as cannabisin B.
The United Nation’s Error Number Two
The other problem with the UN’s definitive method for analyzing cannabis, is with their recommended method of chromatography.
The United Nations recommends using gas chromatography as the method of separating cannabinoids in a sample. However, since the adoption of the
Single Convention on Drug Control in 1961, the UN continues to only focus on the aforementioned three cannabinoids – THC, CBN and CBD. Since the UN wrote their Recommendation for Identifying and Classifying Cannabis, it was subsequently discovered that a 5-type MS GC column is unable to fully separate cannabichromene (CBC) from cannabidiol (CBD). This has resulted in mistaking CBC for CBD.
Since the United Nations established itself as the international competent organization to handle the control of cannabis, it has failed as a competent organization. The Single Convention was organized to control the illicit drug trade. However, prescription medicine continues to harm children, causing unbearable addiction, and violent behavior along with other psychiatric disorders such as suicide .
How is it that society is better off when its constituents are worse off? Herein lies the hypocrisy with cannabis prohibition.
The health benefits of cannabis are astounding and miraculous. Research on the medical benefits of cannabis can be found here; here and here – for starters. The latter link is the number of patent applications filed on cannabinoids by GW Pharma in the UK and the NIH in the US – the only ones allowed access to research and control.
The Antique Cannabis Book has uncovered incriminating evidence against the UN in that the government has known, since the forties, the miraculous epilepsy cure that cannabis provides to those patients.
Who is the UN and how did it come to be? Check this link here
Society is actually defined as those whom control the people. The fallacy is, the people ultimately have control!
CBN is a degraded form of THC – as it does not occur naturally but is an artifact.
Evidence shows that THC appears to degrade at a higher rate in the first year after harvest, relative to subsequent years.
Since the recreational cannabis market is set to commence in 2017, cannabis inventory at the approved licensed producers in Canada far outweigh demand.
What is very disturbing about the Marijuana for Medical Purpose Regulations (MMPR) is that LP’s are only required to disclose the percentage of THC and CBD. Since they are stockpiling their product, licensed producers should be required to disclose CBN.
Included in Canada’s Industrial Hemp Regulations is the type of cultivar or seed Canada allows. Section 14 (3) states: “On and after January 1, 2000, an approved cultivar referred to in subsection (1) must be of a pedigreed status …”
Pedigree status is further defined in subsection 2(2) as: “with respect to seed, means seed that is of foundation status, registered status, or certified status, or seed that is approved by the Canadian Seed Growers’ Association (CSGA) as being breeder seed or select seed. Foundation, registered, and certified status are further defined for seed that is produced in Canada or elsewhere. Seed that is not produced in Canada must meet the standards for varietal purity established by an official certifying agency and be approved by the CSGA.”
This legislation further states that the only two official systems recognized to produce seed of pedigreed status includes:
AASCO- The Association of American Seed Control Officials – and
OECD – The Organization for Economic Cooperation and Development
“a technology where the genome of a host crop is engineered with a foreign donor gene regulated by certain gene regulatory sequences (promoter, terminator, etc.). Crop genetic engineering started in 1983  via expressing of a bacterial gene in tobacco, and the first transgenic (genetically modified or GM) food crop (i.e. Flavr Savr tomato) was commercialized by Calgene Company in 1994 . In crop genetic engineering, genes are randomly inserted into a host plant genome. Although scientists add genes to crops via crop breeding, the breeding progeny is not considered a GM crop because the inserted genes and their regulatory sequences belong to the same host crop genus or in rare cases (for example, in case of cross breeding of oat and barley), to the host’s cross breedable crop. If the donor gene and all of transgene’s regulatory sequences belong to the same crop species or belong to the host’s cross breedable species, the resulting crop is called “cisgenic”. In the cisgenic technology, the cisgene must be an identical copy of the host’s native gene cassette, including its regulatory sequences integrated in the host plant in the normal-sense orientation. The crop intragenic is a technology that inserts gene cassettes containing specific genetic sequences from crops that are belonging to the same breedable gene pool into a host crop genome. In this case, the gene coding sequences (with or without introns) can be regulated by promoters and terminators of different genes as far as those genes that contribute towards the transgene regulation belong to the same cross breedable gene pool .”
How a Biopharmaceutical Company is able to Patent Pot
GW Pharmaceuticals is described as a British based biopharmaceutical company known for its 1994 widely approved drug based on cannabis called Sativex. GW Pharma is currently testing another genetically engineered drug based on the cannabinoid, cannabidiol or CBD, called Epidiolex. Epidiolex is intended to treat severe epilepsy in children and young adults. Of the clinical data made available on 58 patients treated with Epidiolex, 44% or 26 patients showed serious adverse events including two deaths. GW Pharma Test Results for Epidiolex
Biopharmaceuticals are drugs produced using biotechnology. Biotechnology is a process involving the manipulation of biological organisms at the molecular level and usually involves DNA itself. (Before DNA can be manipulated, it needs to first be isolated from the cells).
The word biotechnology was first used in 1919 by Karl Ereky, a Hungarian agricultural engineer, when he introduced the concept of genetic change to produce a particular product using living organisms. Please see this link for more information on the history of biotechnology: Drugs obtained by biotechnology processing
Biotechnology was publicized as offering enormous potential for commercial applications in agriculture and health care.
In accordance with the April 15, 1994 adoption of the World Trade Organization (WTO) TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement, patents are available for any invention in any and all fields of technology, including biotechnology, as long as the product or process is new, involves an inventive step (defined as non-obvious) and is capable of industrial application (defined as useful). 1994 TRIPS Agreement
It should be noted that the WTO’s 1994 TRIPS Agreement is what paved the way for corporations to patent and introduce GMO’s in our food supply.
GW Pharma states it uses their novel proprietary chemovars to target selected cannabinoids. The word “novel” comes from advances in genetics and can be interpreted to mean that they have genetically modified cannabis seeds to produce specific traits. As a result of this biotech process, the TRIPS Agreement allows for patent approval on their novel proprietary chemovars, the same way Monsanto obtained a patent on their novel or GE seeds.
Even the definition of the word ‘Cannabis’ is being changed for the occasion!
Loren W – This Week in Weed TV
Updated 10 April 2016
Over 90% of Australians support Medical Cannabis according to a recent Roy Morgan Survey. But the new Medical Cannabis laws being enacted across Australia are not what the government’s triumphant press releases would have us believe.”
A recent Survey by Roy Morgan research of 644 people <link http://bit.ly/Cannabis-Survey> shows 91% of Australians are supportive of medical Cannabis.
However, what most do not know is Australia is allowing Cannabis to be grown and imported for the first time, but it is all GMO. GMO or Genetically Modified Organism Cannabis has been around since 2011 and before due to breakthroughs in research and Biotechnology by Ethan Russo and GW UK helping in the process and Hortapharm BV providing the genetics and seeds. In…
According to ClinicalTrials.govNabilone is being used in “clinical trials” as a cure for “cannabis use disorder”. (RUFKM)?
Nabilone, (a.k.a. Cesamet owned by Valeant Pharma) is a synthetic or lab made form of the cannabinoid THC (delta-9-tetrahydrocannabinol), the active ingredient in cannabis. Coincidentally, this lab based form resembles the street based synthetic THC known as “spice”or “K2” and is being sold as an incense. K2 or Spice is NOT a natural form of anything, least of all, cannabis. Anything made in a lab, such as spice/k2 is dangerous.
The scientist credited with manufacturing synthetic THC in a lab is – John W Hoffman, PhD, a retired Clemson University chemist whose initials, JWH, is linked with the synthetic cannabinoid JWH-018, a.k.a. Spice.
“The DSM – (Diagnostic and Statistical Manual of Mental Disorders) is said to be the standard classification of mental disorders used for clinical, research, policy, and reimbursement purposes in the United States and elsewhere. It therefore has widespread importance and influence on how disorders are diagnosed, treated, and investigated. Since its first publication in 1952, DSM has been reviewed and revised four times; the criteria in the last version, DSM-IV-TR, were first published in 1994. Since then, knowledge about psychiatric disorders, including substance use disorders, has advanced greatly. To take the advances into account, a new version, DSM-5, was published in 2013.”http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3767415/
With all the hype about the cannabinoid – CBD or Cannabidiol, would it come as a surprise to learn that those in control, have made a very important error?
In the US, the federal government has historically emphasized and funded only research on the potential harm associated with “marijuana” use. In fact, from 2008-2014, the National Institute of Health (NIH) spent an estimated $1.1 BILLION on marijuana research that emphasized abuse and addiction. Yet, the US government has routinely and consistently filed patent applications on every health benefit that cannabis possesses.
The US government (DEA, NIH, etc) determined that gas chromatography was a useful and objective method for separating cannabinoids in a sample to determine its potency. In addition, since their scientists determined that the only other important cannabinoid worth studying was CBD or cannabidiol, they have misled the virgin cannabis patients with their faulty information.
New information obtained from reliable sources show that using gas chromatography can incorrectly show CBC as CBD (cannabichromene as cannabidiol)!!!
To further your understanding about cannabinoids in cannabis as well as the different chromatography testing methods that can identify the cannabinoids in your medicine, please click the following book image: